667 related articles for article (PubMed ID: 30069931)
1. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy.
Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
J Cell Physiol; 2018 Jan; 234(1):348-368. PubMed ID: 30069931
[TBL] [Abstract][Full Text] [Related]
2. Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer.
Wang G; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL
Curr Cancer Drug Targets; 2019; 19(7):534-550. PubMed ID: 30360743
[TBL] [Abstract][Full Text] [Related]
3. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis.
Zhou ZH; Song JW; Li W; Liu X; Cao L; Wan LM; Tan YX; Ji SP; Liang YM; Gong F
J Exp Clin Cancer Res; 2017 Sep; 36(1):130. PubMed ID: 28927426
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill.
Wang G; Wang YZ; Yu Y; Wang JJ
J Ethnopharmacol; 2019 May; 235():255-267. PubMed ID: 30772482
[TBL] [Abstract][Full Text] [Related]
5. The critical role of calcineurin/NFAT (C/N) pathways and effective antitumor prospect for colorectal cancers.
Gang W; Yu-Zhu W; Yang Y; Feng S; Xing-Li F; Heng Z
J Cell Biochem; 2019 Dec; 120(12):19254-19273. PubMed ID: 31489709
[TBL] [Abstract][Full Text] [Related]
6. STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
Wu F; Gao P; Wu W; Wang Z; Yang J; Di J; Jiang B; Su X
J Exp Clin Cancer Res; 2018 Jul; 37(1):144. PubMed ID: 29996891
[TBL] [Abstract][Full Text] [Related]
7. GSH-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment.
Zhao M; Liu Q; Gong Y; Xu X; Zhang C; Liu X; Zhang C; Guo H; Zhang X; Gong Y; Shao C
Cell Cycle; 2016; 15(8):1125-33. PubMed ID: 26950675
[TBL] [Abstract][Full Text] [Related]
8. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
9. TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.
Straus DS
Mol Cancer; 2013 Jul; 12():78. PubMed ID: 23866118
[TBL] [Abstract][Full Text] [Related]
10. Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy.
Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
J Cell Physiol; 2019 May; 234(5):5601-5612. PubMed ID: 30341899
[TBL] [Abstract][Full Text] [Related]
11. Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer.
Graziano F; Ruzzo A; Giacomini E; Ricciardi T; Aprile G; Loupakis F; Lorenzini P; Ongaro E; Zoratto F; Catalano V; Sarti D; Rulli E; Cremolini C; De Nictolis M; De Maglio G; Falcone A; Fiorentini G; Magnani M
Pharmacogenomics J; 2017 Jun; 17(3):258-264. PubMed ID: 26927284
[TBL] [Abstract][Full Text] [Related]
12. VDR-SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment.
Hu PS; Li T; Lin JF; Qiu MZ; Wang DS; Liu ZX; Chen ZH; Yang LP; Zhang XL; Zhao Q; Chen YX; Lu YX; Wu QN; Pu HY; Zeng ZL; Xie D; Ju HQ; Luo HY; Xu RH
Signal Transduct Target Ther; 2020 Sep; 5(1):183. PubMed ID: 32900990
[TBL] [Abstract][Full Text] [Related]
13. Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer.
Kasprzak A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208601
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.
Qiu Z; Guo W; Wang Q; Chen Z; Huang S; Zhao F; Yao M; Zhao Y; He X
Gastroenterology; 2015 Nov; 149(6):1587-1598.e11. PubMed ID: 26248089
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
16. miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis.
Liu S; Xiao Z; Ai F; Liu F; Chen X; Cao K; Ren W; Zhang X; Shu P; Zhang D
Biomed Pharmacother; 2017 Aug; 92():1119-1127. PubMed ID: 28622713
[TBL] [Abstract][Full Text] [Related]
17. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy.
Wang G; Yu Y; Wang YZ; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL
J Cell Physiol; 2019 Aug; 234(10):17023-17049. PubMed ID: 30888065
[TBL] [Abstract][Full Text] [Related]
18. Effects of β-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions.
Zhou L; Zhan ML; Tang Y; Xiao M; Li M; Li QS; Yang L; Li X; Chen WW; Wang YL
Int J Oncol; 2018 Oct; 53(4):1613-1624. PubMed ID: 30066849
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach.
Zafari N; Velayati M; Damavandi S; Pourali G; Mobarhan MG; Nassiri M; Hassanian SM; Khazaei M; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(36):2995-3009. PubMed ID: 36154599
[TBL] [Abstract][Full Text] [Related]
20. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
